Larry Zhang - Jul 24, 2021 Form 4 Insider Report for CASI Pharmaceuticals, Inc. (CASI)

Role
President
Signature
/s/ Cynthia W. Hu, COO (US), Gen Counsel and Secretary
Stock symbol
CASI
Transactions as of
Jul 24, 2021
Transactions value $
$0
Form type
4
Date filed
7/26/2021, 06:08 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CASI Employee Stock Option (Right to Buy) Award $0 -800K -50% $0.00 800K Jul 24, 2021 Common Stock 800K $1.28 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option grant was approved by the Compensation Committee on July 24, 2021. The exercise price per share is the closing market price on July 23, 2021, the last trading day preceding the date of grant.
F2 The stock options will vest as follows: 25 percent on each of the first, second, third and fourth anniversaries of the date of grant.